Glacier Peak Capital LLC cut its holdings in shares of Colony NorthStar (NYSE:CLNS) by 36.1% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 112,882 shares of the real estate investment trust’s stock after selling 63,718 shares during the quarter. Glacier Peak Capital LLC’s holdings in Colony NorthStar were worth $634,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Verition Fund Management LLC acquired a new position in Colony NorthStar during the 1st quarter worth about $297,000. Point72 Asia Hong Kong Ltd acquired a new position in Colony NorthStar during the 1st quarter worth about $151,000. Cubist Systematic Strategies LLC lifted its stake in Colony NorthStar by 454.1% during the 1st quarter. Cubist Systematic Strategies LLC now owns 127,794 shares of the real estate investment trust’s stock worth $718,000 after acquiring an additional 104,730 shares in the last quarter. Freestone Capital Holdings LLC lifted its stake in Colony NorthStar by 24.8% during the 1st quarter. Freestone Capital Holdings LLC now owns 354,335 shares of the real estate investment trust’s stock worth $1,991,000 after acquiring an additional 70,442 shares in the last quarter. Finally, Guggenheim Capital LLC lifted its stake in Colony NorthStar by 6.8% during the 1st quarter. Guggenheim Capital LLC now owns 520,424 shares of the real estate investment trust’s stock worth $2,924,000 after acquiring an additional 32,949 shares in the last quarter. Institutional investors and hedge funds own 83.41% of the company’s stock.

CLNS stock traded up $0.03 during mid-day trading on Thursday, reaching $6.09. The company had a trading volume of 278,439 shares, compared to its average volume of 8,664,228. The company has a quick ratio of 3.68, a current ratio of 3.68 and a debt-to-equity ratio of 1.04. Colony NorthStar has a fifty-two week low of $5.28 and a fifty-two week high of $14.74.

Colony NorthStar (NYSE:CLNS) last posted its quarterly earnings results on Thursday, May 10th. The real estate investment trust reported ($0.14) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.11 by ($0.25). The company had revenue of $666.66 million during the quarter, compared to analyst estimates of $676.48 million. Colony NorthStar had a negative net margin of 9.27% and a negative return on equity of 2.42%. Colony NorthStar’s revenue for the quarter was up 9.8% on a year-over-year basis. During the same period in the prior year, the business earned $0.31 EPS. equities research analysts predict that Colony NorthStar will post 0.49 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, July 16th. Shareholders of record on Friday, June 29th will be given a $0.11 dividend. This represents a $0.44 dividend on an annualized basis and a yield of 7.22%. The ex-dividend date is Thursday, June 28th.

Several equities analysts recently issued reports on the company. ValuEngine lowered Colony NorthStar from a “buy” rating to a “hold” rating in a research note on Friday, February 23rd. Zacks Investment Research raised Colony NorthStar from a “strong sell” rating to a “hold” rating and set a $6.75 target price on the stock in a research note on Monday, May 7th. TheStreet lowered Colony NorthStar from a “c-” rating to a “d+” rating in a research note on Wednesday, March 14th. Keefe, Bruyette & Woods reaffirmed a “hold” rating and issued a $6.00 price target on shares of Colony NorthStar in a research report on Friday, March 2nd. Finally, Wedbush reaffirmed an “outperform” rating and issued a $9.00 price target (down previously from $17.25) on shares of Colony NorthStar in a research report on Tuesday, March 6th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating to the company. Colony NorthStar presently has an average rating of “Buy” and a consensus target price of $11.25.

About Colony NorthStar

Colony NorthStar, Inc (NYSE:CLNS) is a leading global real estate and investment management firm. The Company resulted from the January 2017 merger between Colony Capital, Inc, NorthStar Asset Management Group Inc and NorthStar Realty Finance Corp. The Company has significant property holdings in the healthcare, industrial and hospitality sectors, other equity and debt investments and an embedded institutional and retail investment management business.

Want to see what other hedge funds are holding CLNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colony NorthStar (NYSE:CLNS).

Institutional Ownership by Quarter for Colony NorthStar (NYSE:CLNS)

Receive News & Ratings for Colony NorthStar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colony NorthStar and related companies with MarketBeat.com's FREE daily email newsletter.